Progesterone 8% Vaginal gel (Generic)

Product Overview

Progesterone 8% Vaginal Gel is a prescription‑grade topical formulation designed to supplement endogenous progesterone in women experiencing hormonal deficiencies. Manufactured by Sun Pharmaceutical Industries Ltd, the gel delivers a consistent 8% concentration of progesterone directly to the vaginal mucosa, facilitating absorption into the systemic circulation. The product is supplied in a single‑use tube containing one applicatorful of gel, and it is available in pack sizes of 12, 6, or 3 gel units, allowing patients to choose the most convenient option for ongoing therapy. This medication is indicated for the treatment of female infertility associated with luteal phase deficiency and as part of hormone replacement regimens for menopausal symptoms. The gel’s semi‑solid base ensures slow release, maintaining physiologic hormone levels with minimal peaks. For detailed prescribing information, refer to the U.S. Food and Drug Administration labeling. The product complies with Good Manufacturing Practice (GMP) standards and is packaged in a tamper‑evident tube to ensure integrity.

What is Progesterone 8% Vaginal Gel?

Progesterone 8% Vaginal Gel is a semi‑solid, water‑based preparation that contains eight grams of progesterone per 100 grams of gel, equivalent to an 8% w/v concentration. The active ingredient is identical to the natural steroid hormone produced by the corpus luteum and placenta during the menstrual cycle and pregnancy. In this formulation, the hormone is dissolved in a carrier that allows it to penetrate the vaginal epithelium and enter the bloodstream gradually. The product is marketed as a generic equivalent to branded progesterone gels, offering the same therapeutic effect at a lower cost. Additional information on hormone physiology can be found at the Wikipedia entry on progesterone.

Uses and Benefits

The primary indication for Progesterone 8% Vaginal Gel is the correction of luteal phase deficiency, a condition that can impair implantation and early pregnancy maintenance. By restoring adequate progesterone levels, the gel improves endometrial receptivity and supports successful embryo attachment. In hormone replacement therapy, the gel is used to counteract estrogen‑only regimens that may cause endometrial hyperplasia, thereby providing a balanced approach to menopausal symptom management. Patients often report reduced spotting, more regular menstrual cycles, and improved fertility outcomes. Clinical studies cited by the U.S. National Library of Medicine demonstrate that adjunctive progesterone supplementation can increase live‑birth rates in assisted reproductive technology cycles. Moreover, the topical route minimizes systemic exposure, reducing the risk of oral side effects. Clinical trials have shown a statistically significant improvement in endometrial thickness and pregnancy rates when progesterone gel is added to standard IVF protocols.

How It Works

Progesterone exerts its biological activity by binding to intracellular progesterone receptors (PR) that are expressed in the endometrial lining and other reproductive tissues. Once the gel is applied to the vaginal mucosa, the hormone diffuses across the epithelial barrier and enters the systemic circulation, where it circulates to target organs. In the endometrium, activated PRs modulate the expression of genes involved in decidualization, vascular remodeling, and immune tolerance, creating a receptive environment for implantation. The sustained, low‑grade release provided by the 8% gel mimics the natural luteal‑phase hormone profile, preventing the abrupt hormonal drops that can trigger endometrial shedding. This mechanism is consistent with the physiologic actions described by the National Institutes of Health in their hormone reference guides. Receptor activation also influences the expression of genes responsible for angiogenesis and immune modulation, which are critical for sustaining early pregnancy.

Dosage Guidelines

Progesterone 8% Vaginal Gel is intended for once‑daily nocturnal administration, typically using one full applicator (approximately 1 g of gel) inserted into the vagina before bedtime. The exact dosing schedule may vary based on the clinical indication and physician guidance; for luteal phase support, many reproductive endocrinologists prescribe a single daily dose for 12–14 days following ovulation or embryo transfer. In hormone replacement protocols, the gel may be used cyclically, such as 10 days per month, or continuously under medical supervision. Patients should be instructed to wash their hands before and after application, avoid contact with the eyes, and to replace the cap tightly after each use. Dosage adjustments are not recommended without a healthcare professional’s direction, as over‑dosage could lead to supraphysiologic hormone levels. For detailed dosing references, consult the Drugs.com database. If a dose is missed, the patient should not double the next dose; instead, the regular schedule should be resumed.

Side Effects

Like all hormonal medications, Progesterone 8% Vaginal Gel can produce adverse reactions, although most are mild and transient. Commonly reported side effects include mild vaginal irritation, spotting, or discharge, which typically resolve without intervention. Less frequent systemic effects may comprise headache, breast tenderness, or mood changes resembling premenstrual syndrome. Rare but serious complications can involve allergic dermatitis, severe abdominal pain, or signs of thromboembolic events such as calf swelling or shortness of breath; these require immediate medical attention. The incidence of side effects is generally lower than with oral progesterone due to the localized delivery route. Patients should be aware that prolonged use may lead to endometrial hyperplasia if estrogen therapy is not adequately balanced. For a comprehensive safety profile, refer to the FDA prescribing information.

Warnings and Precautions

Progesterone 8% Vaginal Gel should not be used by individuals with a known hypersensitivity to progesterone or any component of the formulation. The product is contraindicated in patients with active or suspected estrogen‑dependent tumors, unexplained vaginal bleeding, or severe liver disease that impairs hormone metabolism. Caution is advised for women with a history of thromboembolic disorders, hypertension, or migraine with aura, as hormonal therapy may exacerbate these conditions. It is essential to perform a thorough medical evaluation before initiating therapy, including baseline pelvic imaging if indicated. The gel should be stored at room temperature, away from direct heat and moisture, and kept out of reach of children. In case of accidental ingestion, seek emergency medical care. For additional guidance, see the NIH clinical alerts on hormone use. Concurrent use of other hormonal therapies should be reviewed with a physician to avoid excessive dosing.

Frequently Asked Questions

1. What condition does Progesterone 8% Vaginal Gel treat?

   It is primarily prescribed for luteal phase deficiency and as an adjunct in hormone replacement therapy for menopausal women.

2. How should the gel be applied?

   One full applicator is inserted into the vagina once daily, preferably at nighttime, and the cap should be tightly replaced after use.

3. Can the gel be used during pregnancy?

   Use during pregnancy should only occur under a physician’s supervision, as hormonal balance must be carefully monitored.

4. Is a prescription required to purchase this product?

   Yes, a valid prescription from a licensed healthcare provider is required before dispensing Progesterone 8% Vaginal Gel.

5. Where can I find more detailed information about progesterone therapy?

   For evidence‑based resources, visit the MedlinePlus page on progesterone or consult your healthcare professional.

Related Products

• Famotidine 20mg (Generic)
• Omesec 20 mg (Omeprazole)
• Pantocid DSR (Pantoprazole/Domperidone)
• Famotidine 40mg (Generic)
• Famocid 20mg (Famotidine)
• Famocid 40mg (Famotidine)
• Famocid (Famotidine)
• Supatret 0.04% Gel (Tretinoin)
• Supatret 0.1% Gel (Tretinoin)
• Supatret C Gel (Clindamycin/Tretinoin)
• Supatret Gel (Tretinoin)
• Acitretin 25mg (Generic)